Jean-Francois Andre Martini,Jamal Christo Tarazi,Rodolfo Fleury Perini,David J. Mauro
申请号：
US16742657
公开号：
US20200325228A1
申请日:
2020.01.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a VEGFR inhibitor, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L 1.
